跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,407 条关于
“OLC”
全部
4,407
临床试验
2,075
药物
569
机构
1,628
资讯
135
2年前
Unicycive Therapeutics' OLC for Hyperphosphatemia Receives 'Buy' Rating Amidst NDA Submission
去年
Unicycive's OLC Receives FDA Acceptance for Hyperphosphatemia Treatment
去年
Unicycive's OLC Receives FDA Acceptance for Hyperphosphatemia NDA
去年
FDA Accepts Unicycive's Oxylanthanum Carbonate (OLC) Application for Hyperphosphatemia Treatment
去年
FDA Accepts Unicycive's NDA for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients on Dialysis
去年
Unicycive's Hyperphosphatemia Drug, Oxylanthanum Carbonate, Awaits FDA Decision in June
去年
Unicycive and ORIC Pharmaceuticals Receive Buy Ratings Based on Promising Clinical Data
去年
FDA Accepts Unicycive's NDA for Oxylanthanum Carbonate in CKD Patients on Dialysis
去年
FDA Accepts Unicycive's NDA for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients
2年前
Unicycive Submits NDA to FDA for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients on Dialysis
第 1 页,共 14 页
上一页
下一页